Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial - The Lancet
5
$ 11.50
In stock
(432)
Product Description
Probability that short multidrug-resistant tuberculosis treatment
Drug-resistant tuberculosis medical therapy - wikidoc
Estimating post-treatment recurrence after multidrug-resistant
Microorganisms, Free Full-Text
Advances in the development of new tuberculosis drugs and
Economic evaluation protocol of a short, all-oral bedaquiline
Economic evaluation of shortened, bedaquiline-containing treatment
Long-term treatment outcomes in patients with multidrug-resistant
Evaluation of two short standardised regimens for the treatment of
Treatment of isoniazid-resistant tuberculosis with first-line
Investigation of the efficacy of the short regimen for rifampicin
Economic evaluation of shortened, bedaquiline-containing treatment
Antibiotic Steward Bassam Ghanem🆔🌟 on X: 🔥STREAM stage 2
:max_bytes(150000):strip_icc()/INV_CryptoCoinImage_30-bbf4ac3eb28c47b8890e2fa8d5e14469.jpg "Cryptocurrencies To Watch: Week of May 15")
/cdn.vox-cdn.com/uploads/chorus_image/image/72648399/1658071475.0.jpg)
